Amundsen Group

Founded in 1992, EMD Lexigen Research Center develops proprietary immunocytokine and Fc-X fusion protein technologies for treatment of several diseases, such as cancer and AIDS. It works in association with its sister company, EMD Pharmaceuticals, which is a commercial pharmaceutical operation. EMD Pharmaceuticals is engaged in clinical development, manufacture and sale of medical products in the United States with operations in Durham, N.C., and Lexington, Mass. EMD Lexigen Research Center is a subsidiary of Merck KGaA, which is one of the world s oldest productive pharmaceutical companies. It has a staff of more than 33,000 employees and operates over 200 companies in nearly 50 countries. EMD Lexigen Research Center is based in Billerica, Mass.

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website

Constellation Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, specializing in the development of novel cancer therapies. The company focuses on targeting epigenetic pathways to discover and advance potential treatments for various types of cancer. Utilizing cutting-edge research and technology, Constellation Pharmaceuticals is dedicated to advancing the field of oncology through innovative drug discovery and development. The company's mission is to improve patient outcomes and make a meaningful impact in the fight against cancer. Generated from their business information